Cargando…

Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes

PURPOSE: Glycemic control has been recognized as an important modifiable risk factor for diabetic retinopathy (DR). Whether hemoglobin A1c (HbA1c), as an indicator of glycemic control, could modify the genetic susceptibility to severe DR remains to be investigated. This study aimed to investigate wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Kelvin K. K., Cheung, Chloe Y. Y., Lee, Chi-Ho, Fong, Carol H. Y., Kwok, Kelvin H. M., Li, Kenneth K. W., Gangwani, Rita A., Wong, Ian Y. H., Woo, Yu-Cho, Chow, Wing-Sun, Yuen, Michele M. A., Wong, Rachel L. C., Xu, Aimin, Wong, David S. H., Sham, Pak-Chung, Lam, Karen S. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441357/
https://www.ncbi.nlm.nih.gov/pubmed/32756921
http://dx.doi.org/10.1167/iovs.61.10.7
_version_ 1783573280168345600
author Ng, Kelvin K. K.
Cheung, Chloe Y. Y.
Lee, Chi-Ho
Fong, Carol H. Y.
Kwok, Kelvin H. M.
Li, Kenneth K. W.
Gangwani, Rita A.
Wong, Ian Y. H.
Woo, Yu-Cho
Chow, Wing-Sun
Yuen, Michele M. A.
Wong, Rachel L. C.
Xu, Aimin
Wong, David S. H.
Sham, Pak-Chung
Lam, Karen S. L.
author_facet Ng, Kelvin K. K.
Cheung, Chloe Y. Y.
Lee, Chi-Ho
Fong, Carol H. Y.
Kwok, Kelvin H. M.
Li, Kenneth K. W.
Gangwani, Rita A.
Wong, Ian Y. H.
Woo, Yu-Cho
Chow, Wing-Sun
Yuen, Michele M. A.
Wong, Rachel L. C.
Xu, Aimin
Wong, David S. H.
Sham, Pak-Chung
Lam, Karen S. L.
author_sort Ng, Kelvin K. K.
collection PubMed
description PURPOSE: Glycemic control has been recognized as an important modifiable risk factor for diabetic retinopathy (DR). Whether hemoglobin A1c (HbA1c), as an indicator of glycemic control, could modify the genetic susceptibility to severe DR remains to be investigated. This study aimed to investigate whether HbA1c could modulate the genetic susceptibility to severe DR in Chinese patients with type 2 diabetes. METHODS: A total of 3,093 Chinese individuals with type 2 diabetes were included in the cross-sectional case-control study: 1,051 with sight-threatening DR (STDR) and 2,042 without STDR. Sixty-nine top-ranked single nucleotide polymorphisms (SNPs) identified from previous genome-wide association studies were examined for their associations with STDR and proliferative DR as a subgroup analysis. SNPs showing suggestive associations with DR were examined in the stratified analysis by dichotomized HbA1c (<7% vs. ≥7%). An interaction analysis was performed by including an interaction term of SNP × HbA1c in the regression model. RESULTS: Four SNPs showed suggestive associations with STDR. In the stratified analysis, patients with adequate glycemic control (HbA1c <7%) had a 42% lower risk of STDR for carrying each additional protective C allele of COL5A1 rs59126004 (P = 1.76 × 10(−4); odds ratio, 0.58; 95% confidence interval, 0.44–0.77). rs59126004 demonstrated a significant interaction with dichotomized HbA1c on the risk of STDR (P(interaction) = 1.733 × 10(−3)). In the subgroup analysis for proliferative DR, the protective effect of rs59126004 was even more pronouncedly demonstrated (P = 8.35 × 10(−5); odds ratio, 0.37; 95% confidence interval, 0.22–0.60) and it showed similar interactions with dichotomized HbA1c (P(interaction) = 1.729 × 10(−3)). CONCLUSIONS: Our data provided evidence for possible interactions between HbA1c and COL5A1 rs59126004 on the risk of severe DR. These findings may provide new insight into the pathophysiologic mechanism of DR.
format Online
Article
Text
id pubmed-7441357
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-74413572020-08-31 Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes Ng, Kelvin K. K. Cheung, Chloe Y. Y. Lee, Chi-Ho Fong, Carol H. Y. Kwok, Kelvin H. M. Li, Kenneth K. W. Gangwani, Rita A. Wong, Ian Y. H. Woo, Yu-Cho Chow, Wing-Sun Yuen, Michele M. A. Wong, Rachel L. C. Xu, Aimin Wong, David S. H. Sham, Pak-Chung Lam, Karen S. L. Invest Ophthalmol Vis Sci Genetics PURPOSE: Glycemic control has been recognized as an important modifiable risk factor for diabetic retinopathy (DR). Whether hemoglobin A1c (HbA1c), as an indicator of glycemic control, could modify the genetic susceptibility to severe DR remains to be investigated. This study aimed to investigate whether HbA1c could modulate the genetic susceptibility to severe DR in Chinese patients with type 2 diabetes. METHODS: A total of 3,093 Chinese individuals with type 2 diabetes were included in the cross-sectional case-control study: 1,051 with sight-threatening DR (STDR) and 2,042 without STDR. Sixty-nine top-ranked single nucleotide polymorphisms (SNPs) identified from previous genome-wide association studies were examined for their associations with STDR and proliferative DR as a subgroup analysis. SNPs showing suggestive associations with DR were examined in the stratified analysis by dichotomized HbA1c (<7% vs. ≥7%). An interaction analysis was performed by including an interaction term of SNP × HbA1c in the regression model. RESULTS: Four SNPs showed suggestive associations with STDR. In the stratified analysis, patients with adequate glycemic control (HbA1c <7%) had a 42% lower risk of STDR for carrying each additional protective C allele of COL5A1 rs59126004 (P = 1.76 × 10(−4); odds ratio, 0.58; 95% confidence interval, 0.44–0.77). rs59126004 demonstrated a significant interaction with dichotomized HbA1c on the risk of STDR (P(interaction) = 1.733 × 10(−3)). In the subgroup analysis for proliferative DR, the protective effect of rs59126004 was even more pronouncedly demonstrated (P = 8.35 × 10(−5); odds ratio, 0.37; 95% confidence interval, 0.22–0.60) and it showed similar interactions with dichotomized HbA1c (P(interaction) = 1.729 × 10(−3)). CONCLUSIONS: Our data provided evidence for possible interactions between HbA1c and COL5A1 rs59126004 on the risk of severe DR. These findings may provide new insight into the pathophysiologic mechanism of DR. The Association for Research in Vision and Ophthalmology 2020-08-05 /pmc/articles/PMC7441357/ /pubmed/32756921 http://dx.doi.org/10.1167/iovs.61.10.7 Text en Copyright 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Genetics
Ng, Kelvin K. K.
Cheung, Chloe Y. Y.
Lee, Chi-Ho
Fong, Carol H. Y.
Kwok, Kelvin H. M.
Li, Kenneth K. W.
Gangwani, Rita A.
Wong, Ian Y. H.
Woo, Yu-Cho
Chow, Wing-Sun
Yuen, Michele M. A.
Wong, Rachel L. C.
Xu, Aimin
Wong, David S. H.
Sham, Pak-Chung
Lam, Karen S. L.
Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes
title Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes
title_full Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes
title_fullStr Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes
title_full_unstemmed Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes
title_short Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes
title_sort possible modifying effect of hemoglobin a1c on genetic susceptibility to severe diabetic retinopathy in patients with type 2 diabetes
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441357/
https://www.ncbi.nlm.nih.gov/pubmed/32756921
http://dx.doi.org/10.1167/iovs.61.10.7
work_keys_str_mv AT ngkelvinkk possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT cheungchloeyy possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT leechiho possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT fongcarolhy possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT kwokkelvinhm possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT likennethkw possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT gangwaniritaa possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT wongianyh possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT wooyucho possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT chowwingsun possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT yuenmichelema possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT wongrachellc possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT xuaimin possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT wongdavidsh possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT shampakchung possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes
AT lamkarensl possiblemodifyingeffectofhemoglobina1congeneticsusceptibilitytoseverediabeticretinopathyinpatientswithtype2diabetes